Validation and update of a clinical score model to predict technical difficulty of colorectal endoscopic submucosal dissection: a multicenter prospective cohort study

医学 内镜黏膜下剥离术 接收机工作特性 前瞻性队列研究 队列 逻辑回归 内科学 放射科 外科
作者
Bing Li,Jingyi Liu,Dong-Li He,Xinjian Wan,Rong Wan,Quan‐Lin Li,Qiang Shi,Shi‐Lun Cai,Zhipeng Qi,Zhong Ren,Ming‐Yan Cai,Ping‐Hong Zhou,Yunshi Zhong
出处
期刊:Gastrointestinal Endoscopy [Elsevier BV]
卷期号:99 (3): 387-397.e6 被引量:3
标识
DOI:10.1016/j.gie.2023.10.037
摘要

Background and Aims The Zhongshan colorectal endoscopic submucosal dissection (CR-ESD) score model was proposed to grade the technical difficulty of CR-ESD. The objective of this study was to prospectively validate and update the score model. Methods A multicenter prospective cohort analysis of CR-ESD was conducted. Individual data on patients, lesions, and outcomes of CR-ESD were used to validate the original model and further refine the difficulty of the prediction model. Data were randomly divided into discovery and internal validation cohorts. A multivariate Cox regression analysis was conducted on the discovery cohort to develop an updated risk-scoring system, which was then validated. Results Five hundred forty-eight patients with 565 colorectal lesions treated by ESD from 4 hospitals were included. In the prospective validation cohort, the area under the receiver-operating characteristic (ROC) curve for the original model was .707. Six risk factors were identified and assigned point values: tumor size (2 points for 30-50 mm, 3 points for ≥50 mm), at least two-thirds circumference of the lesion (3 points), tumor location in the cecum (2 points) or flexure (2 points), laterally spreading tumor-nongranular lesions (1 point), preceding biopsy sampling (1 point), and NBI International Colorectal Endoscopic type 3 (3 points). The updated model had an area under the ROC curve of .738 in the discovery cohort and of .782 in the validation cohort. Cases were categorized into easy (score = 0-1), intermediate (score = 2-3), difficult (score = 4-6), and very difficult (score ≥7) groups. Satisfactory discrimination and calibration were observed. Conclusions The original model achieved an acceptable level of prediction in the prospective cohort. The updated model exhibited superior performance and can be used in place of the previous version. (Clinical trial registration number: ChiCTR2100047087.) The Zhongshan colorectal endoscopic submucosal dissection (CR-ESD) score model was proposed to grade the technical difficulty of CR-ESD. The objective of this study was to prospectively validate and update the score model. A multicenter prospective cohort analysis of CR-ESD was conducted. Individual data on patients, lesions, and outcomes of CR-ESD were used to validate the original model and further refine the difficulty of the prediction model. Data were randomly divided into discovery and internal validation cohorts. A multivariate Cox regression analysis was conducted on the discovery cohort to develop an updated risk-scoring system, which was then validated. Five hundred forty-eight patients with 565 colorectal lesions treated by ESD from 4 hospitals were included. In the prospective validation cohort, the area under the receiver-operating characteristic (ROC) curve for the original model was .707. Six risk factors were identified and assigned point values: tumor size (2 points for 30-50 mm, 3 points for ≥50 mm), at least two-thirds circumference of the lesion (3 points), tumor location in the cecum (2 points) or flexure (2 points), laterally spreading tumor-nongranular lesions (1 point), preceding biopsy sampling (1 point), and NBI International Colorectal Endoscopic type 3 (3 points). The updated model had an area under the ROC curve of .738 in the discovery cohort and of .782 in the validation cohort. Cases were categorized into easy (score = 0-1), intermediate (score = 2-3), difficult (score = 4-6), and very difficult (score ≥7) groups. Satisfactory discrimination and calibration were observed. The original model achieved an acceptable level of prediction in the prospective cohort. The updated model exhibited superior performance and can be used in place of the previous version. (Clinical trial registration number: ChiCTR2100047087.)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
匿明完成签到,获得积分20
刚刚
刚刚
popura_YY完成签到 ,获得积分10
刚刚
超级小飞侠完成签到 ,获得积分10
刚刚
魔幻冰淇淋完成签到 ,获得积分10
刚刚
Zhang完成签到,获得积分10
刚刚
星星发布了新的文献求助10
1秒前
搜集达人应助AidenZhang采纳,获得10
1秒前
last_champion发布了新的文献求助10
1秒前
1秒前
SS2D完成签到,获得积分10
1秒前
2秒前
奋斗完成签到,获得积分10
2秒前
晚风发布了新的文献求助30
2秒前
LIJIANGSHENG发布了新的文献求助10
3秒前
kookery发布了新的文献求助10
3秒前
刘芬发布了新的文献求助10
3秒前
abcd_1067完成签到,获得积分10
3秒前
3秒前
英吉利25发布了新的文献求助30
4秒前
仁爱的从雪完成签到,获得积分10
4秒前
Jasper应助高贵振家采纳,获得10
4秒前
4秒前
花蝴蝶发布了新的文献求助10
4秒前
十六发布了新的文献求助10
5秒前
英姑应助长情天川采纳,获得10
5秒前
小城故事和冰雨完成签到,获得积分10
5秒前
5秒前
lemon完成签到 ,获得积分10
5秒前
wendinfgmei完成签到,获得积分10
5秒前
之尔完成签到,获得积分10
5秒前
小陈1122发布了新的文献求助10
5秒前
phg022发布了新的文献求助10
6秒前
木木木完成签到,获得积分10
6秒前
ruanyh发布了新的文献求助10
6秒前
7秒前
wisliudj发布了新的文献求助50
7秒前
清梦完成签到,获得积分10
7秒前
7秒前
xmy完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6952187
求助须知:如何正确求助?哪些是违规求助? 8636402
关于积分的说明 18312965
捐赠科研通 6395121
什么是DOI,文献DOI怎么找? 3082313
关于科研通互助平台的介绍 2127808
邀请新用户注册赠送积分活动 2059206